Canaccord Genuity Starts Ultragenyx Pharma (RARE) at Buy
Tweet
Share
E-mailGet Alerts RARE Hot Sheet
Price: $14.86 -4.8%
Rating Summary:
13 Buy, 12 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 7 | Down: 6 | New: 31
Rating Summary:
13 Buy, 12 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 7 | Down: 6 | New: 31
Join SI Premium – FREE
Canaccord Genuity initiated coverage on Ultragenyx Pharma (NASDAQ: RARE) with a Buy rating and a price target of $60.00.
For an analyst ratings summary and ratings history on Ultragenyx Pharma click here. For more ratings news on Ultragenyx Pharma click here.
Shares of Ultragenyx Pharma closed at $48.65 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Oppenheimer Assumes Inova Technology, Inc. (INVA) at Outperform
- Desjardins Resumes Primaris REIT (PMZ-U:CN) at Buy
- UBS Starts CoreWeave (CRWV) at Buy, 'Strong Growth Offsets Credit Concerns'
Create E-mail Alert Related Categories
Hot New Coverage, New CoverageRelated Entities
Canaccord GenuitySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
